Aap Implantate AG: Business description, financial summary, 3yr and interim financials, key statistics/ratios and historical ratio analysis.
Provider: Reuters Investment Profile
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.
aap Implantate AG Confirms FY 2013 Guidance
aap Implantate AG announced that it reaffirms its sales growth forecast of approximately 10% to EUR 40 million and its EBITDA growth forecast of 15% to EUR 7.0 million. According to I/B/E/S estimates, analysts on average are expecting the Company to report fiscal year 2013 revenue of EUR 38.79 million and EBITDA of EUR 7.12 million.
Latest Developments for Aap Implantate AG
Latest Key Developments in Medical
- Coloplast A/S gives FY 2014/2015 revenue guidance in line with analysts' estimates
- Pihsiang Machinery Mfg Co Ltd to transfer stake in Pihsiang Energy Technology Co., Ltd to Hong Kong-based company
- Daiken Medical Co Ltd lowers year-end dividend forecast for FY 2015
- KAWAMOTO CORP expects extraordinary loss and lowers consolidated mid-year and full-year outlook for FY 2015
- Share this
- Digg this